{
    "code": "02020334",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020334",
    "time": "2020-02-25 12:25:59",
    "許可證字號": "衛署藥輸字第020334號",
    "註銷狀態": "已註銷",
    "註銷日期": "84\/03\/08",
    "註銷理由": "移轉（申請商）",
    "製造許可登錄編號": "",
    "有效日期": "88\/02\/28",
    "發證日期": "83\/02\/28",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202033408",
    "中文品名": "丹那諾",
    "英文品名": "DANAZOL",
    "適應症": "腦下腺前葉抑制劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DANAZOL ( EQ TO CYCLOMEN )",
    "限制項目": "02輸　入",
    "申請商名稱": "0902101100  美商美國溫莎大藥廠股份有限公司台灣分公司",
    "申請商地址": "台北巿民生東路三段１５６號８樓之１之２之３",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0009000  NYCOMED PUERTO RICO INC.",
            "製造廠廠址": "BARCELONETA. PUERTO RICO 00617.90 PARK AVENUE, NEW YORK, NY 10016 U.S.A.",
            "製造廠公司地址": "90 PARK AVENUE, NEW YORK, NY 10016 U.S.A.",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6808000400",
            "成分名稱": "DANAZOL ( EQ TO CYCLOMEN )",
            "含量描述": "98.0-102.0",
            "含量": "",
            "單位": "%"
        }
    ]
}